Yishan Medical closes Series A for home maternal & infant diagnostics

What's the deal? Yishan Medical, a Chinese consumer medical hardware company focused on maternal and infant care, has closed its Series A and A1 funding rounds. The rounds were led by Hong Kong-based Kapok Fund, with participation from Hong Kong's Watten Capital, Kangaroo Mama Group, and Singapore's Solebay Capital.

Yishan Medical develops non-invasive diagnostic devices for home use across the pregnancy and childcare cycle. Its product line includes fertility monitors for women and neonatal jaundice detectors for newborns.

Why now? Demand for at-home medical devices — particularly in maternal and infant health — is growing as consumers seek hospital-grade diagnostics without clinic visits. Non-invasive technology has matured enough to make consumer-friendly devices viable.

The signal: Yishan Medical's cross-border investor syndicate — spanning Hong Kong, Singapore, and the maternal care brand Kangaroo Mama Group — hints at ambitions beyond mainland China, even as the Shenzhen-based company remains at the early growth stage. The participation of a consumer brand alongside financial investors suggests a distribution-led expansion strategy, blending capital with channel access in a niche where trust and clinical credibility are hard to build from scratch.

Source: itjuzi.com